Human T-cell lymphotropic virus type I (HTLV-I) proviral DNA viral load among asymptomatic patients and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis

Brazilian Journal of Medical and Biological Research

Volumn 38, Issue 11, 2005, Pages 1643-1647

  Montanheito, P A ^a   de Oliveira, A C Penalva ^b   Posada Vergara, M P ^b   Milagres, A C ^a   Tauil, C ^a   Marchiori, P E ^a   Duarte, A J S ^a   Casseb, J ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO DE INFECTOLOGIA EMÍLIO RIBAS   (Brazil)

Author keywords

HTLV I; HTLV I DNA viral load; HTLV I associated myelopathy tropical spastic paraparesis (HAM TSP)

Indexed keywords

POL PROTEIN; VIRUS DNA;

ARTICLE; CONTROLLED STUDY; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; MAJOR CLINICAL STUDY; MOLECULAR PROBE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATIENT MONITORING; PERIPHERAL BLOOD MONONUCLEAR CELL; RANK SUM TEST; REAL TIME POLYMERASE CHAIN REACTION; RETROVIRUS INFECTION; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; STRUCTURAL GENE; VIRUS LOAD;

DNA VIRUSES; HTLV; HUMAN T CELL LYMPHOTROPIC VIRUS TYPE I; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 27944458871     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/s0100-879x2005001100011     Document Type: Article

References (20)

1. Gessain A, Barin F, Vernant JC et al. (1985). Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet, 2: 407-410.
2. Osame M, Usuku K, Izumo S et al. (1986). HTLV-I associated myelopathy: A new clinical entity. Lancet, 1: 1031-1032.
3. Kaplan JE, Osame M, Kubota H et al. (1990). The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. Journal of Acquired Immune Deficiency Syndromes, 3: 1096-1101.
4. Iwasaki Y (1993). Human T cell leukemia virus type I infection and chronic myelopathy. Brain Pathology, 3: 1-10.
5. Shimamoto Y, Funai N, Watanabe M et al. (1996). Increased production of interferon gamma but not interleukin 4 in human T-lymphotropic virus type I carriers. International Journal of Hematology, 64: 111-118.
6. Jacobson S (2002). Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease. Journal of Infectious Diseases, 186 (Suppl 2): S187-S192.
7. Hollsberg P & Hafler DA (1995). What is the pathogenesis of human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis? Annals of Neurology, 37: 143-145.
8. Mellors JW, Kingsley LA, Rinaldo Jr CR et al. (1997). Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Annals of Internal Medicine, 126: 946-954.
9. Osame M (2002). Pathological mechanisms of human T-cell lymphotropic virus type I-associated myelopathy (HAM/TSP). Journal of Neurovirology, 8: 359-364.
10. Yoshida M, Osame M, Kawai H et al. (1989). Increased replication of HTLV-I in HTLV-I-associated myelopathy. Annals of Neurology, 26: 331-335.
11. Kubota R, Fujiyoshi T, Izumo S et al. (1993). Fluctuation of HTLV-I proviral DNA in peripheral blood mononuclear cells of HTLV-I-associated myelopathy. Journal of Neuroimmunology, 42: 147-154.
12. Osame M (1992). Mielopatia asociada con el HTLV-I (HAM/PET) en Japon. In: Zaninovic V, Galindo J & Blank A (Editors), Enfermedades Asociadas con el Virus HTLV-I. Fundación MAR, Cali, Colombia, 87-96.
13. Laurendeau I, Bahuau M, Vodovar N et al. (1999). TaqMan PCR-based gene dosage assay for predictive testing in individuals from a cancer family with INK4 locus haploinsufficiency. Clinical Chemistry, 45: 982-986.
14. Vet JA, Majithia AR, Marras SA et al. (1999). Multiplex detection of four pathogenic retroviruses using molecular beacons. Proceedings of the National Academy of Sciences, USA, 96: 6394-6399.
15. Dehee A, Cesaire R, Desire N et al. (2002). Quantitation of HTLV-I proviral load by a TaqMan real-time PCR assay. Journal of Virological Methods, 102: 37-51.
16. Nagai M, Usuku K, Matsumoto W et al. (1998). Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. Journal of Neurovirology, 4: 586-593.
17. Yamano Y, Nagai M, Brennan M et al. (2002). Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8(+) T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP). Blood, 99: 88-94.
18. Jeffery KJ, Usuku K, Hall SE et al. (1999). HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proceedings of the National Academy of Sciences, USA, 96: 3848-3853.
19. Furukawa Y, Saito M, Matsumoto W et al. (2003). Different cytokine production in tax-expressing cells between patients with human T cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis and asymptomatic HTLV-I carriers. Journal of Infectious Diseases, 187: 1116-1125.
20. Matsuzaki T, Nakagawa M, Nagai M et al. (2001). HTLV-I proviral load correlates with progression of motor disability in HAM/TSP: analysis of 239 HAM/TSP patients including 64 patients followed up for 10 years. Journal of Neurovirology, 7: 228-234.